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Human GATA3 haploinsufficiency leads to HDR (hypoparathyroidism, deafness and renal dysplasia) syndrome, demonstrating that the
development of a specific subset of organs in which this transcription factor is expressed is exquisitely sensitive to gene dosage. We previously
showed that murine GATA-3 is essential for definitive kidney development, and that a large YAC transgene faithfully recapitulated GATA-3
expression in the urogenital system. Here we describe the localization and activity of a kidney enhancer (KE) located 113 kbp 5′ to the Gata3
structural gene. When the KE was employed to direct renal system-specific GATA-3 transcription, the extent of cell autonomous kidney rescue in
Gata3-deficient mice correlated with graded allelic expression of transgenic GATA-3. These data demonstrate that a single distant, tissue-specific
enhancer can direct GATA-3 gene expression to confer all embryonic patterning information that is required for successful execution of
metanephrogenesis, and that the dosage of GATA-3 required has a threshold between 50% and 70% of diploid activity.
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Mammalian kidney morphogenesis progresses through three
sequential stages with the first two embryonic kidneys, the
pronephros and mesonephros, being transitory structures
(Dressler, 2002; Gilbert, 2000; Kuure et al., 2000). By late
embryonic day (e) 9, the nephric duct has fully extended
posteriorly. The definitive kidney begins to develop at e11 when
the ureteric bud (UB) sprouts from the nephric duct. This initial
sprouting is triggered by glial cell line-derived neurotrophic
factor (GDNF) secreted from the metanephric blastema (Davies
and Fisher, 2002; Sainio et al., 1997). A variety of additional
morphogenetic signals lead to further outgrowth and dichot-
omous branching of the UB to form the mature renal collecting
system (Davies and Fisher, 2002; Yu et al., 2004). The UB in
turn signals to the surrounding nephrogenic mesenchyme,⁎ Corresponding author. Fax: +1 734 763 1166.
E-mail address: engel@umich.edu (J.D. Engel).
0012-1606/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2006.09.030inducing it to undergo epithelial differentiation to ultimately
form much of the nephron.
Of the germline mutations that have been analyzed in mice,
loss-of-function alleles for the genes encoding transcription
factors Lim1, Pax2, Pax2 plus Pax8 and GATA-3 most often
lead to extension failure of the nephric duct (Bouchard et al.,
2002; Lim et al., 2000; Shawlot and Behringer, 1995; Tsang et
al., 2000). GATA-3 belongs to a six-member family of
transcription factors that share conserved zinc fingers, which
recognize the consensus sequence (A/T)GATA(A/G) (Ko and
Engel, 1993; Merika and Orkin, 1993; Yamamoto et al., 1990).
GATA-3 is expressed in many tissues and cell types and has
been shown in several cases to play essential roles in their
differentiation (George et al., 1994; Hendriks et al., 1999;
Kaufman et al., 2003; Lakshmanan et al., 1998; Lim et al.,
2000; Ting et al., 1996; van der Wees et al., 2004; van
Doorninck et al., 1999; Zheng and Flavell, 1997). Germ line
deletion of murine Gata3 was initially reported to result in
grossly normal Gata3 heterozygous mutant mice (Pandolfi et
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tion of noradrenergic insufficiency leading to secondary cardiac
failure (Lim et al., 2000). Pharmacologic rescue of GATA-3-
deficient embryos (to late gestation) with synthetic noradrena-
line intermediates revealed an array of mutant phenotypes,
including renal agenesis, that were previously masked by the
early in utero lethality (Lim et al., 2000).
To facilitate systematic and rapid isolation of regulatory cis-
elements within any extended genomic domain, we previously
reported the use of YACs (Lakshmanan et al., 1999; Zhou et al.,
1998) and BAC-traps (Khandekar et al., 2004) to assess large
swaths of the genome for enhancer activity in vivo. This led to
the identification and crude localization of a Gata3 kidney
enhancer lying within a 662-kbp YAC. To evaluate the in vivo
contribution of an enhancer to a given biological process, we
proposed to establish the necessary and sufficient contribution
of a regulatory protein under the control of any enhancer to a
discrete developmental event. Here, we describe the localization
of a Gata3 kidney enhancer (KE) that lies 113 kbp 5′ to the
structural gene, and the in vivo interrogation of its contribution
to generation of the definitive kidney.
To evaluate the capacity of the enhancer to fully delineate
GATA-3 functions during nephrogenesis, we generated trans-
genic lines that expressed tissue-specific GATA-3 at various
abundances relative to its endogenous level under the direct
transcriptional control of the isolated KE. KE-directed GATA-3
transgenes (TgKE-G3) were then examined in Gata3 null (lacZ
knock-in) mice (Gata3z/z:TgKE-G3) in order to assess their
ability to specifically rescue metanephrogenesis. In the rescued
compound mutants, the degree of renal development is directly
proportional to the transgene-derived GATA-3 abundance,
reflecting GATA-3 gene dosage dependence in executing the
nephrogenic program as seen in HDR patients. Compound
mutants with Tg expression of greater than 50% of endogenous
GATA-3 levels undergo normal nephrogenesis, while equal to
or less than 50% levels of GATA-3 result in a spectrum of
intermediate defective nephric duct and ureteric bud phenotypes
in midgestation as well as various deficiencies in the definitive
kidneys of late gestation embryos. The renal phenotypic
variations seen in the partially rescued compound mutants are
in some ways reminiscent of the spectrum of highly variable
clinical nephric defects encountered in GATA3 haploinsufficient
HDR syndrome patients, suggesting that Gata3 compound
mutant mice might represent a unique experimental model to
study kidney deficiencies observed in the human condition.
Results
Localization of a distant Gata3 kidney enhancer
Previously, we generated transgenic lines harboring the
B125Z mouse Gata3 YAC (the genome sequence-revised
endpoints are −451 to +211 kbp, with respect to the GATA-3
translational start site; Lakshmanan et al., 1998, 1999), which
was tagged with a lacZ reporter gene (Lakshmanan et al., 1999).
Detailed analyses of B125Z transgenic lines indicated that β-
galactosidase staining was detected throughout early anddefinitive nephrogenesis, consistent with previous in situ
hybridization studies (George et al., 1994; Labastie et al.,
1995; Lakshmanan et al., 1999). Detailed pulsed-field gel
electrophoresis analyses indicated that one line (#71) harboring a
5′ truncated YAC [with a breakpoint that mapped imprecisely
between −70 and −116 (±20) kbp] still retained urogenital lacZ
expression (data not shown, and Lakshmanan et al., 1999).
Previous transgenic analyses of two other smaller YACs
indicated that B124Z (spanning −451 to +69 kbp), but not
C4Z (−40 to +69 kbp of the Gata3 locus), could recapitulate
urogenital lacZ staining (Lakshmanan et al., 1998, and
unpublished). These and other observations allowed us to
conclude deductively that a kidney enhancer (KE) must reside in
the interval between −40 and −116 kbp 5′ to the Gata3
structural gene. We therefore performed end fragment rescue to
retrieve terminal genomic sequences from Gata3 YACs that had
3′ endpoints lying within that interval (B143 and B157;
Fig. 1A). A rescued 9.2-kbp EcoRI genomic DNA fragment
was recovered from the YAC B143 3′ terminus, which localized
to −110 kbp (Fig. 1B1; data not shown and Lakshmanan et al.,
1998).
To determine whether the rescued B143 3′ end fragment
contained kidney enhancer activity, we subcloned it into
pG3lacZ (formerly named −308placZ; see Materials and
methods; Lieuw et al., 1997) for founder (F0) transgenic
analysis (Fig. 1B). X-gal staining was detected in the nephric
duct and the UB of all (6/6) e11.5 transgenic embryos
(Fig. 1C1); the urogenital β-galactosidase staining pattern
recapitulated that observed in whole mount X-gal-stained
B125Z transgenic (Lakshmanan et al., 1999) as well as
heterozygous Gata3 lacZ knock-in embryos (first panel from
left, Fig. 1D, Gata3+/z; Hendriks et al., 1999; van Doorninck
et al., 1999). Hence, we concluded that the 9.2-kbp end
fragment recovered from YAC B143 contains a Gata3 KE.
Further analysis resulted in the experimental refinement of this
KE activity to a 1.3-kbp fragment that recapitulated the
urogenital expression pattern in the majority of e11.5/e12.5
transgenic F0 embryos (Figs. 1B2–B5 and C2–C5).
To ascertain if the 1.3-kbp KE-directed lacZ reporter gene
expression recapitulated the temporal profile of Gata3, we
generated stable lines of this reporter construct. When examined
during early- to mid-embryogenesis, transgene expression was
strictly confined to the developing nephric ducts, and later in the
sprouting ureteric buds, of e9.0–10.5 transgenic embryos
(Supplemental Fig. 1). This mirrored the temporal staining
profile in Gata3+/z embryos with similar numbers of somites,
which however displayed a more extensive X-gal staining
pattern in tissues in addition to nephric derivatives. Thus, the
1.3-kbp KE was capable of activating reporter gene expression
when endogenous GATA-3 expression was initiated. By birth,
the transgene is expressed in the epididymis, seminal vesicles
and vas deferens of transgenic males in addition to the kidneys
and ureters (second panel from left, Fig. 1D), as do YAC B125Z
transgenic and Gata3+/z neonates (Lakshmanan et al., 1998;
below).
To verify coincident expression at the cellular level, we
replaced the reporter gene in pG3lacZ with eGFP and generated
Fig. 1. Localization of a Gata3 kidney enhancer. (A) The murine Gata3 locus is schematically illustrated with the six exons indicated. The GATA-3 translational
initiation site in exon 2 is designated as nucleotide 1. The approximate 3′ endpoints of the B143 and B157 YACs (Lakshmanan et al., 1999) are indicated. (B)
Individual test constructs (1–7, with sizes indicated) were cis-linked to theGata3minimal promoter driving lacZ reporter gene, and then tested for urogenital enhancer
activity in F0 transgenic assays. The transgenic data for each construct are summarized on the right with the numbers representing the total number of embryos positive
for urogenital X-gal staining and lacZ transgene(s) as determined by PCR genotyping, respectively. For generating GATA-3 transgenic lines in the rescue experiments
(below), the lacZ reporter gene in construct 5 was replaced by GATA-3 cDNA. (C) Linearized expression constructs (1–7, see B) were microinjected into fertilized
oocytes. e11.5–12.5 embryos were stained for β-galactosidase activity. All test constructs were capable of driving lacZ expression in the nephric duct and the
branching ureteric bud, mimicking the X-gal staining pattern seen in Gata3+/z embryos. The number shown in the upper right hand corner corresponds to the number
of the injected test construct (B). (D) An X-gal-stained whole mount e11.5 Gata3+/z embryo. Note the staining in the nephric duct and the bifurcating ureteric bud,
indicated by the arrow and arrowhead, respectively (left panel). The urogenital system from a male neonate of a stable transgenic line harboring construct 5 (B) was
subjected to X-gal staining (second panel from left). Note that X-gal stains the kidneys, the ureters and the Wolffian duct-derived genital tracts, as previously reported
in Gata3 lacZ YAC transgenic mice (Lakshmanan et al., 1999). B, bladder; e, epididymis; sv, seminal vesicles; t, testis; u, ureter; v, vas deferens. (Third through sixth
panels) A kidney section from an e15.5 Gata3+/z embryo bearing transgene construct 5 directing eGFP reporter expression was co-stained with anti-β-galactosidase
and anti-GFP antibodies, conjugated with Cy3 and FITC fluorochromes, respectively, and then post-stained with hematoxylin and eosin (H&E). Note the co-
localization of both fluorescent signals in the merged image (far right panel).
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fragment (Fig. 1B5). After crossing to Gata3+/z mice, the
kidneys of compound mutant (Gata3+/z:TgKE-GFP) neonates
were examined by immunofluorescent staining. Fully coin-
cident staining (Fig. 1D, merge) of transgenic (Fig. 1D, anti-
GFP) and endogenous (Fig. 1D, anti-β-gal) gene products was
observed. Hence, the KE recapitulates the authentic spatiotem-
poral expression pattern of endogenous GATA-3 in the kidney.
To further refine the limits of the Gata3 kidney enhancer, we
examined conserved genomic sequences from comparable
domains of the Gata3 locus across several vertebrate species,
including human, rat, dog and chicken. Within the 1.3-kbp, a
non-repetitive, non-genic conserved sequence element (CSE) of415-bp shared the greatest identity among all species examined
(Fig. 1B6). In the mouse Gata3 locus, this CSE lies 113 kbp 5′
to the translational initiation site. To determine whether the CSE
was also sufficient to direct urogenital expression, it was cis-
linked singly or in triplicate (Fig. 1B6, B7) to pG3lacZ and
examined in F0 transgenic assays. The CSE conferred correct
lacZ patterning in the developing urogenital system of only a
small fraction (2/16) of transgenic founders (Fig. 1C6). In
contrast, triplication of the CSE directed urogenital system-
specific lacZ expression in the majority of transgenic embryos
(10/14; Fig. 1C7). Therefore, subsequent transgenic experi-
ments were performed using the larger 1.3-kbp KE (Fig. 1B5)
rather than the 415-bp minimal CSE.
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transgenes
The eGFP gene in KEpG3GFP (Figs. 1B5 and C, anti-
GFP) was replaced by a full-length GATA-3 cDNA (Ko et al.,
1991) and used to generate transgenic animals, which were
identified by PCR and Southern blotting analyses. Eighteen
independent lines (Fig. 2A) bearing from 1 to 14 transgene
copies were recovered.
To characterize the tissue specificity of each transgenic
line, we performed RT-PCR on total RNA isolated from
individual tissues of Gata3+/+ Tg-positive and -negative
littermates with primers that distinguished between endogen-
ous and Tg-derived GATA-3 mRNAs (Materials and
methods). These analyses demonstrated that in some lines,
such as H3, properly spliced Tg-derived GATA-3 transcripts
were detected exclusively in the kidneys (Fig. 2B), whereas
endogenous GATA-3 mRNA was detected in many other
tissues where Gata3 is normally expressed (Fig. 2B and data
not shown; George et al., 1994; Yamamoto et al., 1990). In
other lines, however, the transgenes were also expressed
ectopically, probably reflecting promoter activation exerted by
cis elements located in the vicinity of random Tg integration
sites (data not shown).
To quantify Tg expression levels relative to endogenous
GATA-3 mRNA in the kidneys, we performed semi-quantitative
RT-PCR under conditions of limiting template dilution or
amplification cycle number. Multiple samples were examined in
triplicate. In the line that expressed transgenic GATA-3 most
abundantly, H14 (Fig. 2C), Tg-derived mRNA was detected atFig. 2. Characterization of KE-directed GATA-3 transgenes. (A) Southern blot a
independent TgKE-G3 lines were hybridized with radiolabeled probe synthesized usin
numbers were determined by densitometry of this and other blots (using the GATA-3
KE-GATA-3 line TgH3. RNA from the indicated tissues was reverse-transcribed into
endogenous (endo) GATA-3 mRNA (Methods). A non-transgenic littermate (non-Tg
while HPRT mRNAwas used as the positive control for both RNA isolation and first
lung; Mb, midbrain; GI, small intestine; B, bone; Sk, skin. (C) Semi-quantitative RT-P
e16.5 Gata3+/+kidneys of TgH14, TgH3 and TgB6 lines were subjected to cDNA sy
transgene-specific (Tg) or endogenous GATA-3-specific (endo) primers (Methods).70% of diploid abundance, while a second line, H3 (Fig. 2C),
expressed the TgKE-G3 at 50% of wild-type diploid levels. Two
intermediate lines, G6 and H12, expressed Tg-specific mRNAs
at 40% or 30% of diploid expression levels, respectively (data
not shown), while most other lines (e.g., B6, 5% of wild-type
GATA-3 abundance, Fig. 2C) expressed transgenic GATA-3 at,
or less than, 5% of endogenous levels. None of the transgenic
lines exhibited visible gain-of-function phenotypes in the wild-
type genetic background.
KE-directed GATA-3 expression rescues renal organogenesis in
GATA-3-deficient mice
We wished to determine whether the 1.3-kbp Gata3 KE was
sufficient to direct GATA-3 reconstitution of the entire
nephrogenic developmental program. To address this question,
we assessed the rescue potential of each of the KE-directed
transgenes in a Gata3 null background. The five well-
characterized Tg lines expressing high (H14 and H3),
intermediate (G6 and H12) or low (B6) GATA-3 mRNA levels
were independently interbred with Gata3+/z mice to generate
compound mutant progeny (Gata3+/z:TgKE-G3). Pregnant dams
from Gata3+/z×Gata3+/z:TgKE-G3 intercrosses were fed syn-
thetic catechol intermediates to overcome the midgestational
lethality normally observed in Gata3 null embryos (Lim et al.,
2000). Embryos (e11.5–e16.5) were subjected to X-gal staining
and PCR genotyping. In general, the expected Mendelian
complement of all possible genotypes was observed, but with
fewer homozygous mutants recovered as gestation progressed
(Table 1).nalysis of KE-GATA-3 transgenic lines. BamHI-digested genomic DNAs of
g a 1-kbp EcoRI/AflII genomic fragment bearing the Gata3 KE. Transgene copy
3′ UTR as probe; not shown) and varied from 1 to 14. (B) RT-PCR analysis of
cDNA and then amplified using primers specific for transgene-derived (Tg) or
) was employed as the negative control for the transgene-specific PCR primers,
strand cDNA synthesis. Legend: K, kidney; Th, thymus; Li, liver; H, heart; Lu,
CR analysis of GATA-3 mRNA from representative transgenic lines. RNAs from
nthesis and two-fold serial dilutions of the cDNA were analyzed using either
Table 1
Summary of genotypes from Gata3+/z×Gata3+/z:TgKE-G3 matings
Transgene Gata3+/+ Gata3+/z Gata3z/z Gata3+/+:Tg Gata3+/z:Tg Gata3z/z:Tg
TgH14 (70%)* 19 35 13 22 54 27
TgH3 (50%) 17 27 8 18 26 11
TgG6 (40%) 7 23 9 12 12 8
TgH12 (30%) 17 30 17 11 24 12
TgB6 (5%) 16 30 8 12 29 14
Total (expected)** 76 (72) 145 (145) 55 (72) 75 (72) 145 (145) 72 (72)
Embryos (e10.5–e16.5) were collected from pregnant dams fed with catechol intermediates to rescue the noradrenaline deficiency. *Percentages in parentheses
indicate the expression levels of transgene(s) relative to wild-type endogenous GATA-3 diploid levels. **Expected based on a Mendelian distribution of heterozygotes.
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of normal genitourinary structures was observed, with no
apparent defects in either organ size or morphology (Figs. 3B,
C) in comparison to wild-type littermates (Fig. 3A). In
contrast, while the majority of the e11.5 Gata3+/z embryos
developed long, well-formed nephric ducts and generated
normally branching ureteric buds (Fig. 3D), we infrequently
noticed accessory ureteric buds (Figs. 3E and F; arrowheads)
in e11.5 Gata3+/z embryos (summarized in Table 2) that
could be ascribed to Gata3 haploinsufficiency. This haploin-
sufficient defect is rarely seen as definitive morphogenesis
nears completion (e16.5) since aberrant kidneys were very
infrequently observed in late gestational or adult heterozy-
gotes (Figs. 3B, C).
Consistent with previous observations, pharmacologically
rescued e16.5 Gata3z/z embryos were most often anephric (Lim
et al., 2000). Gata3z/z female and male embryos also lacked
uteri or epididymides/vasa deferentia derived from the (GATA-Fig. 3. Haploinsufficient urogenital phenotype in Gata3+/z embryos. Whole
mount urogenital systems recovered from e16.5 non-transgenic Gata3+/+ male
(A), Gata3+/z male (B) or Gata3+/Z female (C) embryos stained for β-
galactosidase activity. Both macroscopic inspection and detailed histological
analyses have failed to yield evidence for any morphological aberrations in
urogenital structures. (D–F) Urogenital systems isolated en bloc from individual
e11.5 Gata3+/z mutants with nephric duct and ureteric bud developmental
variations. Panel D is a urogenital filet taken from a Gata3+/z embryo; the
majority of e11.5 embryos displayed similar morphology, including a smooth
nephric extension that contacted the urogenital sinus and a developing ureter
terminated by a singly bifurcated bud. (E) A small accessory bud adjacent to the
ureteric bud proper is evaginating from the nephric duct (arrowhead). (F) A fully
duplicated ureteric bud (arrowhead).3-negative) Mullerian or nephric/Wolffian ducts, respectively
(Figs. 4A, B). The latter observations are consistent with those
of Kobayashi et al. (2005), who demonstrated (following
nephric duct-specific lim1 inactivation) that the nephric duct
influences the formation, but not the initiation, of the Mullerian
duct. While the gonads were of normal size in the Gata3mutant
embryos, the testes, which were histologically normal (not
shown), were often incompletely descended (Fig. 4B, arrow-
heads). In some embryos, a thin, atretic remnant of the nephric
duct could be seen terminating abnormally within the body wall
musculature (Figs. 4C–E, arrowheads). In e11.5 Gata3z/z
embryos, bilaterally absent or abnormally shortened ducts
were frequently observed (Lim et al., 2000). These shortened
nephric ducts often appeared to initiate properly along the
nephrogenic cord, but then veered and terminated into the
lateral body wall (Table 2 and Fig. 4F, arrowhead).
When the TgKE-G3 lines were bred onto the Gata3 null
background, we observed variably rescued urogenital pheno-
types that correlated best with the Tg expression levels amongst
the multiple lines. In e16.5 Gata3z/z:TgH14 embryos, which
expressed Tg-derived GATA-3 mRNA most abundantly (70%
of diploid level), a full complement of genitourinary structures,
including bilateral kidneys, ureters, Wolffian/nephric duct- and/
or Mullerian duct-derived structures, was observed (Table 3;
Fig. 5A, female, and B, male). Specifically, both kidneys
appeared to be of normal size, with typical nephrogenic zones
and underlying mature cortical tissue, when examined histolo-
gically (not shown), as observed in wild-type and heterozygous
e16.5 littermates (Figs. 3A–C). Thus, TgH14 completely
rescued urogenital development in Gata3z/z embryos of both
early (e11.5; Fig. 5C and Table 2) and late (e16.5; Figs. 5A, B
and Table 3) gestational ages. Similarly, a second high
expressing line H3, with Tg expression at approximately
50%, also rescued definitive nephrogenesis at late gestation
(data not shown). Curiously, as in Gata3 heterozygous
embryos, we also detected accessory UBs in midgestational
compound mutant embryos of this line (Table 2).
Of the e13.5–16.5 Gata3z/z compound mutant embryos
complemented with intermediate levels of GATA-3 expression
(lines TgG6 and TgH12), the majority exhibited unilateral renal
agenesis as well as hypoplastic metanephric kidneys (Figs. 5E
and F and Table 3). Only one out of these 9 rescued mutants
exhibited bilateral renal agenesis. Truncated ureters and, rarely,
duplicated kidneys were observed in the Gata3z/z:Tg mutants
that were rescued with intermediate transgenic GATA-3 levels
Table 2
Nephric duct and ureteric bud phenotypes in e11.5/12.5 Gata3+/z, Gata3z/z:Tg and Gata3z/z embryos
Genotype Complete ND Shortened ND ND on BW No ND Accessory UB Separate “floating” UB No UB
Gata3+/z 21/21 (B)* 2/21
TgHi:Gata3z/z 12/12 (B) 1/12**
TgInt:Gata3z/z 4/8 (B) 1/8 (B) 1/8 (U) 1/8 1/8 (B) 1/8
1/8 (U) 1/8 (U)
TgLo:Gata3z/z 1/5 (B) 4/5 (U) 2/5 (U) 5/5
2/5 (U)
Gata3z/z 1/13 (U) 1/13 (U) 11/13 (B) 13/13
2/13 (U)
TgHi, H14 and H3; TgInt, G6 and H12; TgLo, B6. Complete ND=nephric duct (ND) fully extended beyond the normal ureteric budding site; shortened ND=nephric
duct failing to extend bilaterally (B) or unilaterally (U) to or beyond the normal ureteric budding site; ND on BW=shortened ND that veered laterally to terminate into
the body wall instead of extending caudally towards the cloaca; no ND=no visible caudal extension of ND beyond the anterior mesonephric tubules; accessory
UB=smaller, duplicated ureteric bud; separate, “floating”UB=a discontinuous, ureteric bud associated with shortened ND; no UB=lack of visible ureteric buds. *No.
of affected/total no. of embryos. **A TgH3 embryo.
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mutants (40% of diploid GATA-3) displayed multiple
abnormalities (e.g., discontinuous, “floating” ureteric buds
associated with shortened nephric ducts; Fig. 5D). Careful
histological examination of serial sections from one such
embryo indicated an absence of ductal structures in the vicinity
of the floating UB (not shown). This morphological aberration
is reminiscent of the nephric duct degeneration observed in
e11.5–e13.5 embryos after conditional inactivation of lim1 (in
the nephric duct at e9.5), which results in progressive ductal
atrophy (Kobayashi et al., 2005).
Finally, in the single low-expressing Tg line analyzed, renal
agenesis in compound mutant Gata3z/z:Tg embryos was never
reversed (Table 2). In these embryos, the renal developmental
status at e16.5 resembled that observed in Gata3z/z embryos
(Table 3), with vestigial rostral nephric ducts that were
shortened and often extended laterally, abruptly terminating
within the body wall.
In summary, complementation of the Gata3 germ line
mutation by this graded series of KE-G3 Tg alleles resulted in
either no (by low-expressing transgenic lines), partial (by
intermediate-expressing transgenic lines) or complete (by
high-expressing transgenic lines) restoration of metanephric
development, indicating that there is a physiologically critical
threshold of GATA-3 that is required for normal renal
morphogenesis. Full restoration of metanephrogenesis wasFig. 4. Full penetrance of nephric duct extension defects in pharmacologically rescued
form the definitive metanephric kidney and a uterus or vas deferens, respectively, w
majority of the pharmacologically rescued null embryos either lacked the nephric duc
the nephrogenic cord to terminate abruptly in the lateral body wall (C=e14.5, D–E=e
in A); UBl, urinary bladder; T, testis (arrowheads in B).achieved by the highest-expressing transgenic line (70% of
diploid levels), while lines expressing at lower (50% of
diploid) levels only partially restored kidney development. In
specific, the haploinsufficient mice exhibited nephric pheno-
types that were indistinguishable from null mutant mice in
which nephrogenesis was rescued by a transgene providing
50% of diploid abundance. Hence, from these data, we deduce
that the severity of renal dysmorphia in rescued Gata3 null
mutants declined with increasing transgenic GATA-3 abun-
dance, and that the physiologically critical level of GATA-3
required for renal morphogenesis lies somewhere between
50% (as in heterozygotes or Gata3z/z:TgH3 embryos) and 70%
(in Gata3z/z:TgH14 embryos). Additionally, the data demon-
strate that the KE is sufficient for completion of metane-
phrogenesis in a rigorous in vivo assay.
Discussion
GATA3 haploinsufficiency in man and mice
GATA-3 is essential for renal morphogenesis since the loss-
of-function mutation in humans and mice leads to kidney
developmental defects, in addition to other developmental
abnormalities (Lim et al., 2000; Van Esch et al., 2000). In
patients, the loss of one GATA3 allele leads to the pathophy-
siological triad of parathyroid, otic and renal aberrations, theGata3 null mutant embryos. e16.5 Gata3z/z females (A) and males (B) failed to
hile the testes (B, arrowheads) are histologically normal (data not shown). The
t or had a thin, atretic duct that veered from its normal path of caudal extension in
13.5, F=e11.5; arrowheads in C–F). Ov, ovaries; Ad, adrenal gland (arrowheads
Table 3
Kidney and ureter phenotypes in e13.5 to e16.5 Gata3+/z, Gata3z/z:Tg and Gata3z/z embryos
Genotype Full rescue Double ureter Unilateral kidney Hypoplastic kidney Double kidney ND on BW Anephric
TgHi:Gata3z/z 5/5* 1/5
TgInt:Gata3z/z 2/9 6/9 7/9 1/9 2/9 1/9
TgLo:Gata3z/z 3/3 3/3
Gata3z/z 6/16 16/16
TgHi, H14; TgInt, G6 and H12; TgLo, B6. Full rescue=complete restoration of normal sized bilateral kidneys, ureters and normally positioned gonads; double
ureter=unilaterally duplicated ureter; unilateral kidney=unilateral renal agenesis; hypoplastic kidney=abnormally smaller kidney; double kidney=unilateral renal
duplication; ND on BW=nephric duct remnant terminating on body wall; anephric= lack of kidneys. *No. of affected/total no. of embryos.
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renal hypoplasia or dysplasia to complete agenesis. Inactivation
of both Gata3 alleles in mice leads to midembryonic demise
(Pandolfi et al., 1995), and subsequent studies demonstrated
that the cause of death was attributable to secondary cardiac
failure as a consequence of a primary deficiency in catechola-
mine biosynthesis (Lim et al., 2000). After dietary supplemen-
tation with synthetic catechol intermediates, pharmacologically
rescued late gestational Gata3 null embryos were noted to
suffer developmental defects in multiple organ systems. Of
immediate relevance here, it was apparent that a complete loss
of Gata3 function led to a nearly complete failure to properly
elaborate the inner ear (Karis et al., 2001; Lillevali et al., 2004),
the parathyroid gland and the definitive kidney (Moriguchi et
al., 2006), precisely the same organs affected in human HDR
syndrome. Additionally, Gata3 null animals fail to generate
either thymic or mammary glands (Moriguchi and Lim,
unpublished observations), and more recently, hearing defects
were reported in Gata3 heterozygous mutant animals (van der
Wees et al., 2004). While we did not observe gross
genitourinary defects in older Gata3+/z embryos or adults in
the present study, early renal patterning defects were noted
infrequently in midgestational heterozygotes, thus reflecting the
highly variable kidney deficiencies that have been documented
in HDR patients. Since we do not know what percentage of
HDR patients have severe nephric aberrations in comparison to
those that have very mild or no deficiencies, we can
conservatively conclude that Gata3 haploinsufficiency likely
results in no more severe nephric dysfunction in mice than in
men.Fig. 5. Urogenital rescue in Gata3 null mutants is dependent on KE-directed GATA-
directed GATA-3 transgene (TgH14), urogenital development in e16.5 Gata3z/z fema
diploid expression) usually rescued the early (e11.5) renal haploinsufficiency (C).
expressing GATA-3 at 40% of wild-type levels) led to defects at e11.5 (D; an atret
complete duct with an non-bifurcating bud). Complementation with TgG6 also led to a
and in this instance, unilateral renal duplication with bilaterally shortened ureters th
(expressing 30% of diploid GATA-3 levels) often led to unilateral renal agenesis anGata3 organ-specific dosage sensitivity
Haploinsufficiency has previously been reported to result in
phenotypic manifestations in mice and humans (Seidman and
Seidman, 2002). However, in only a few instances has it been
elucidated how a two-fold reduction in a gene product would
result in phenotypic presentation. The complexity of the
problem is confounded further by gene modifiers and epigenetic
events, which can expand the phenotypic variability of a
haploinsufficiency syndrome or trait.
Here, we described the identification of a kidney enhancer
element, located far 5′ to the gene, that regulates Gata3
expression in the developing renal system, and the use of this
enhancer to drive the expression of a GATA-3 transgene to
rescue the metanephric agenesis observed in GATA-3-deficient
embryos. While a previous study did not observe a correlation
between reconstitution of nephrogenesis in rescued c-ret−/−
mutants and transgene expression level using a heterologous
kidney-specific promoter to rescue c-Ret expression (Srinivas et
al., 1999), we found that the ability of the Gata3 KE-directed
transgene to complement the renal defect in the Gata3
homozygous mutants is complete and related to its expression
level, clearly demonstrating GATA-3 dosage sensitivity in renal
development. Since we determined transgenic GATA-3 expres-
sion abundances at a single developmental time point (e16.5) in
Gata3+/+:Tg kidneys, the caveats remain that the abundance of
transgene expression may not completely mimic that of the
endogenous gene throughout development, nor can we dismiss
the possibility that there may be compensatory or autoregula-
tory mechanisms in play that lead to higher or lower than3 transgene expression level. When bred to the most abundantly expressing KE-
les (A) and males (B) is fully rescued. Furthermore, the H14 transgene (70% of
In a minority of examples, rescue with an intermediate level transgene (TgG6,
ic nephric duct with a discontinuous “floating” ureteric bud and a contralateral
berrant kidney morphogenesis by e16.5: the kidneys were most often hypoplastic
at failed to contact the urinary bladder (E), while complementation with TgH12
d hypoplasia (F).
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in the heterozygotes.
Despite these caveats, these data show that the success of
renal morphogenic rescue correlates directly with GATA-3
levels and that the physiologically critical level is greater than
50% (the precise amount remains indeterminate) of diploid
GATA-3 levels. Additionally, data from the analyses of other
Gata3 hypomorphic alleles indicate that the critical threshold
for proper development differs among the various GATA-3-
expressing organs and tissues, and that renal morphogenesis is
one of the more sensitive to perturbation (Moriguchi and
Engel, unpublished observations). These observations are also
consistent with clinical reports on HDR patients: for example,
despite an absolute requirement for GATA-3 in murine and
human T cell development, HDR patients are immunologi-
cally competent (Muroya et al., 2001). Since GATA-3 is not
the only GATA family member expressed in T lymphocytes
(Yamagata et al., 1997), GATA factor redundancy may
partially explain the relatively intact adaptive immune
function in HDR patients.
Gata3 transgenic mice may be useful for dissecting
individual mechanistic steps leading to proper renal morpho-
genesis, which will shed light on the developmental events that
have gone awry in individuals with duplicated ureters and
kidneys or with renal dysplasia. The mystery behind GATA3
haploinsufficiency as it affects development of a specific subset
of organ systems (kidneys, parathyroid glands and sensory
neurons in the ear) remains both unresolved and intriguing. As
we identify genetic regulatory domains that dictate GATA-3
expression as well as the downstream targets of GATA-3 in
other anatomical sites using the experimental tools described
here, we may be able to mechanistically decipher how a two-
fold reduction in this transcription factor leads to dysgenesis of
the renal and other organ systems, but does not affect the
development of the numerous other tissues in which the same
factor is vitally required. Similarly, detailed analysis of the 415-
bp minimal KE should reveal possible direct regulators that
control its activity. Since the minimal element contains more
than a dozen potential binding sites for different transcription
factors, detailed analysis (mutagenesis of individual binding
sites followed by cotranfection studies, genetic epistasis tests
for resolving which member of a given family of regulators is
responsible for epithelium-specific, KE-specific activation) will
require considerable effort before final experimental resolution.
The Gata3 locus is large
The data presented here show that Gata3 expression in the
developing urogenital system can be fully complemented by an
enhancer element lying 113 kbp 5′ to the GATA-3 translation
initiation site. This characterization as a “distant” localization,
however, may be deceptively overstated: we have now surveyed
>1.5 Mbp surrounding the Gata3 locus (Moriguchi, Kuroha,
Lim and Engel, unpublished observations) using the BAC-trap
strategy (Khandekar et al., 2004), and we have found that
numerous enhancers controlling Gata3 spatiotemporal activity
that are yet to be discovered lie even further (i.e., more than500 kbp) from the structural gene. Within the limited context of
studies that have examined the transcriptional control over
regulatory genes (e.g., those encoding transcription factors,
signaling molecules and their receptors), this noteworthy fact is
nonetheless no longer surprising: enhancers lying >1 Mbp from
the Shh and Sox9 structural genes have been clearly documented
(Bishop et al., 2000; Lettice et al., 2003). How or why some
mammalian patterning genes achieve such remarkably accurate
developmental specificity from such vast genomic distances,
often bypassing activation of intervening transcription units, is a
fundamental conundrum that is yet to be resolved or even
seriously addressed.Materials and methods
Plasmid constructions
To rescue genomic sequences from mouse Gata3 YACs B143 and B157, we
performed end fragment rescue as described previously (Lakshmanan et al.,
1998). Briefly, EcoRI-digested YAC DNAwas self-ligated and transformed into
E. coli. A 9.2-kbp Gata3 genomic DNA fragment was retrieved from the B143
end fragment-rescued plasmid and subcloned into pG3lacZ (previously named
−308placZ), consisting of the Gata3 proximal minimal promoter at −1310-bp,
with respect to the Gata3 translational start site, driving the lacZ reporter gene
(Lieuw et al., 1997). Smaller DNA fragments of the 9.2-kbp test insert were
analyzed for KE activity by exploiting unique restriction sites in the parental
fragment and then subcloning those fragments into pG3lacZ (Fig. 1B). PCR-
assisted cloning was used to generate lacZ expression vectors containing single
or triplicated copies of the conserved 415-bp CSE. The fidelity of PCR
amplification was verified by sequencing.
To generate kidney-specific expression of GATA-3 or eGFP, DNA encoding
either protein was used to replace the lacZ gene in pG3lacZ. A 1.3-kbp SwaI/
HindIII Gata3 KE, which was shown to retain kidney enhancer activity in
transgenic expression founder assays, was used to direct transgenic expression
of both the GATA3 and eGFP DNAs.
Transgenic mice
To generate transgenic animals, expression constructs were microinjected
into CD1 fertilized oocytes following standard protocols (Nagy et al., 2003). To
identify transgenic animals, DNAs from yolk sac or tail snip of founder animals
were used for genotyping by PCR or Southern blotting for the presence of
transgene (lacZ, eGFP or GATA-3). For F0 analyses, embryos were harvested
from foster mothers at appropriate gestational days, stained with X-gal and
processed for photography, as previously described (Lieuw et al., 1997). For
stable lines expressing KE-directed GATA-3, F2 and subsequent generations of
progeny (continually backcrossed onto a CD1 outbred background) were
examined for Tg copy number and Tg-derived transcript accumulation. The
generation and characterization of Gata3/lacZ heterozygous (Gata3+/Z) mice
was previously reported (Hendriks et al., 1999; van Doorninck et al., 1999).
PCR genotyping of progeny from Gata3+/Z intercrosses was performed as
described (Kaufman et al., 2003). For kidney-specific rescue, Gata3+/Z:TgKE-G3
animals were mated with Gata3+/z mice and the dams were given ad libitum
drinking water containing catechol intermediates, as described previously
(Kaufman et al., 2003; Lim et al., 2000). Embryos from timed pregnancies or
neonates were processed for X-gal staining followed by photography and
genotyping by PCR.
Semi-quantitative RT-PCR
Semi-quantitative RT-PCR was performed as previously described (Tani-
moto et al., 2000). Total RNAwas isolated from tissues using ISOGEN (Nippon
Gene). First strand cDNA was synthesized using 1 μg of total RNA and
Superscript II reverse transcriptase (Invitrogen) in a 20-μl reaction volume. For
576 S.L. Hasegawa et al. / Developmental Biology 301 (2007) 568–577template-limiting PCR, 1 μl of cDNA was serially diluted two-fold and
amplified for 35 cycles. Amplified products were fractionated on polyacryla-
mide gels and quantified using a phosphoimager (Molecular Dynamics). PCR
primers used were as follows: HPRT [5′ gcttgctggtgaaaaggac 3′ (S) and 5′
caacttgcgctcatcttagg 3′ (AS)], GATA-3 [5′ atcaagcccaagcgaaggct 3′ (S) and 5′
gaatgcagacaccacctcgagctcc 3′ (AS, specific for endogenous mRNA)] or 5′
ccgcctacttgtcatcgtcgtccttgtagtc 3′ (AS, transgene-specific).
Immunofluorescence staining
Anti-eGFP and anti-β-galactosidase immunofluorescence was performed
essentially as described (Khandekar et al., 2004).Acknowledgments
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